Intrexon Corporation
(NYSE : XON)

( )
XON After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.79%79.141.2%$541.48m
AMGNAmgen Inc.
-0.28%185.991.2%$522.30m
GILDGilead Sciences, Inc.
0.08%71.520.9%$518.25m
BIIBBiogen Inc.
0.16%297.341.2%$439.96m
NKTRNektar Therapeutics
-3.97%55.865.6%$383.38m
SRPTSarepta Therapeutics, Inc.
-2.63%149.6516.6%$325.83m
VRTXVertex Pharmaceuticals Incorporated
-0.67%156.571.9%$253.87m
REGNRegeneron Pharmaceuticals, Inc.
-2.34%329.042.6%$243.76m
ILMNIllumina, Inc.
-0.56%286.053.5%$191.71m
AAgilent Technologies, Inc.
0.40%63.041.5%$180.09m
BLUEBluebird Bio, Inc.
2.32%187.3515.7%$156.91m
ALXNAlexion Pharmaceuticals, Inc.
1.04%125.812.0%$149.34m
EXASExact Sciences Corporation
-0.74%68.8225.5%$144.87m
BMRNBioMarin Pharmaceutical Inc.
0.09%98.434.4%$139.42m
INCYIncyte Corporation
-1.28%72.492.5%$126.38m

Company Profile

Intrexon Corp. is a biotechnology company, which engages in the business of synthetic biology. It focuses on on programming biological systems to alleviate disease, remediate environmental challenges, and provide sustainable food and industrial chemicals. The firm offers UltraVector, RheoSwitch, cell systems informatics, protein engineering, and antibody discovery. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.